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seizures and a mesial temporal lobe
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A 12-year-old adolescent presented with refractory seizures and was found to have a
mesial temporal lobe lesion. The patient underwent biopsy and was diagnosed with
an arteriovenous malformation. Supratentorial lesions in the pediatric population can
have a large variety of underlying etiologies, which can be challenging to differentiate
on neuroimaging. In this report, we discuss the key features on MRI of several neoplastic,
vascular, and infectious processes that can aide in the diagnosis.
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Clinical Case
A 12-year-old adolescent presented to his primary care physician with new onset staring episodes.
His family stated the patient would be unresponsive during these episodes and would make a
“wringing” motion with his hands. The episodes lasted about 1min and were not preceded by
an aura. After the episodes, the patient felt tired. At the time of presentation, the episodes were
occurring daily. He was initially started on carbamazepine by his primary care physician who
thought the episodes were consistent with seizures and he was referred to neurology. His past
medical history was unremarkable. He was a full-term birth and had normal development. He was
performing well in school and involved in several athletic activities.
On presentation to neurology, it was thought his episodes were consistent with complex partial
seizures. His neurologic examination was unremarkable. His seizures were well controlled on the
carbamazepine, which was continued and an EEG and MRI brain with and without contrast were
ordered. The EEG was unremarkable, but the MRI brain showed a left mesial temporal lobe lesion
(Figure 1). At this time, he was referred to neurosurgery for further evaluation and management.
There was concern that this lesion was consistent with an underlying neoplasm, specifically a glial
tumor, ependymoma, or dysembryoplastic neuroepithelial tumor (DNET). He underwent a left
pterional craniotomy with partial resection of the left temporal lobe lesion. The pathology from this
lesion was not diagnostic for any specific pathology. It demonstrated a firm collagenized reactive
process that could represent an infectious, neoplastic, or reaction to a vascular malformation. He
did well post-operative. He continued to have occasional seizures every couple of months and
levetiracetam was added. After the addition of levetiracetam, he had better control, but over the
next several years both his carbamezepine and levetiracetam were increased after an increase in
seizure activity. The patient continued to have an annual MRI brain with and without contrast that
demonstrated no change in the lesion. Five years after the initial surgery, the patient continued
to have seizures (approximately 2–3/month) and repeat surgery was discussed for possible better
seizure control. He underwent a second left temporal craniotomy for resection of the remaining
mesial temporal lobe lesion. His immediate post-operative course was complicated by right-sided
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FIGURE 1 |MRI brain with and without contrast obtained at onset of seizures demonstrating left mesial temporal lobe lesion. (A) Axial DWI (B) Axial T2
(C) Axial T1 post-contrast (D) Coronal T2 (E) Coronal T1 pre-contrast (F) Coronal T1 post-contrast.
hemiplegia with left-sided intraventricular hemorrhage and an
ischemic stroke affecting the left thalamus and left middle cere-
bral peduncle. Pathology from this biopsy was consistent with
a congenital arteriovenous malformation (AVM) with secondary
leptomeningeal fibrosis. He was discharged to an inpatient reha-
bilitation facility and he had partial recovery of strength on his
right side to the point and he was able to ambulate with a cane.
He was seen in follow-up and at 28months post-surgery his
levetiracetam was discontinued over 6weeks and at 34months
post-surgery the carbamazepine was discontinued over 12weeks.
He has remained seizure free over the 3 years since surgery.
Pathology
A biopsy of the left mesial temporal lobe lesion was analyzed
(Figure 2). On microscopic examination, the cortex was slightly
hypercellular. There was evidence of gliosis with focal brightly
eosinophilic Rosenthal fiber formation. Additionally, there was
evidence of abnormal vessels with thickenedwalls within the brain
parenchyma and one with extensive calcification. The GFAP and
CD34 immunostain demonstrated cortex with reactive gliosis and
intraparenchymal thin-walled as well as thickened blood vessels
with intervening brain tissue. The leptomeninges showed exten-
sive fibrosis and mineralization. A synaptophysin stain showed
positive process in the neuropil, but is negative in the neuronal cell
bodies. A Ki-67 proliferation index was <1%. These histological
and immunohistochemical features were most consistent with an
AVM with secondary leptomeningeal fibrosis.
Discussion
This case demonstrates the difficulty in distinguishing neoplas-
tic, vascular, and infectious lesions on imaging. Additionally the
patient presented in this case had an initial biopsy that was incon-
clusive, which further supports the importance of gleaning as
much information as possible from imaging studies. In this report,
we provide a brief summary of the classic imaging characteristics
of a variety of neoplastic, vascular, and infectious etiologies and
discuss how this may have helped with the initial work-up and
diagnosis of this patient.
In the pediatric population, supratentorial cortical based
tumors represent 25–40% of all brain tumors (1). Most of these
tumors are low grade resulting in a slow progression with a mean
latency to diagnosis of 8months (1). Table 1 provides a summary
of the typical imaging characteristics of the low- and high-grade
tumors often found in pediatric patients. In general, low-grade
tumors appear more homogeneous, whereas high-grade tumors
often have a more heterogeneous appearance because of cystic,
hemorrhagic, and necrotic portions. Additionally, most tumors
are hyperintense on T2/FLAIR. The patient presented in this
case had a lesion that was primarily hypointense on T2, which
is in contrast to most neoplastic lesions, but could be consistent
with a low-grade pilocytic astrocytoma, pleomorphic xanthoas-
trocytoma, or meningioma. Of these three tumor types, the only
one that demonstrates strong contrast enhancement, as in the
patient reported, is a meningioma. The patient’s lesion did not
appear dural based, but this is not always readily apparent on
imaging.
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FIGURE 2 | Left temporal lobe lesion biopsy demonstrating hypercellular
cortex (A). Pyramidal neurons are readily appreciated [(B), arrows] on higher
power (100). At 200 magnification gliosis and focal brightly eosinophilic
Rosenthal fiber formation [(C), arrows] are appreciated. A CD34 immunostain
(D) highlights the endothelial cells of the intraparenchymal vessels which are
slightly increased in number.
TABLE 1 | Summary of characteristic imaging features of supratentorial tumors seen in the pediatric population (1–3).
Tumor type Common location T2/FLAIR T1 T1 post-contrast Mass effect
Pilocytic
astrocytoma
Cerebellum, brainstem, optic nerve,
thalamus
Hyperintense (cystic portion),
Iso/hypointense (solid)
Iso/hypointense Cyst wall may have ring
like enhancement
None
Fibrillary
astrocytoma
Cerebellum, brainstem, optic nerve,
thalamus
Hyperintense Hypointense No enhancement Minimal
Pleomorphic
xanthoastrocytoma
Parietal/temporal Isointense Isointense Positive enhancement Extensive
Gangliogliomas Frontal and temporal Hyperintense Iso/hypointense 20% Enhance Minimal
Dysembryoplastic
neuroepithelial
Frontal/temporal Well defined hyperintense rim Iso/hypointense Rarely enhances Minimal
Oligodendrogliomas Cerebral hemispheres Hyperintense Iso/hypointense Occasional enhancement
in higher grades
Minimal
Ependymomas Fourth Ventricle, less likely third or
lateral ventricle
Hyperintense or
heterogeneous
Hypointense Mixed, solid portions will
enhance
Yes
Meningioma Frontoparietal parasagittal
convexities, falx, tentorium cerebelli,
sphenoid wings, olfactory groove,
and tuberculum sella
Isointense or heterogeneous Iso/hypointense Positive enhancement Variable
Glioblastoma Cerebral Hyperintense Hypointense Ring-like Significant
Gliomatosis cerebri Diencephalon/basal ganglia 50% Incomplete
enhancement
Minimal
Primitive
neuroectodermal
Fronto/parietal Hyperintense (cystic/necrotic) Hyperintense
(hemorrhage)
Positive enhancement Minimal
Atypical
teratoid/rhabdoid
Vermis/cerebellopontine angle,
occasional cortical
Isointense or slightly
hyperintense
Heterogeneous Positive enhancement
Lymphoma Anywhere, classically periventricular Heterogeneous Hypo/isointense Positive enhancement Minimal
Infectious and vascular etiologies would also be on the differen-
tial for this patient. Infectious etiologies to consider are an abscess
and limbic encephalitis. Abscesses can have a range of characteris-
tics onMRI depending on the age of the lesion. Early in the course
it will have an ill-defined shape with patchy enhancement (4). As
the lesionmatures, it will become well defined with a thin rim like
enhancement (4). On T1 the lesion will initially be hypointense
or isointense and with time will develop a hyperintense rim. It
will always appear hyperintense on T2, but with progression will
develop a hypointense rim (4). Initially, the lesion will have some
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mild restricted diffusion and with time will become very bright
centrally on diffusion imaging. Limbic encephalitismay have been
considered given the mesial temporal lobe location with a clinical
history of seizure, but this process is ill-defined and hyperintense
on T2 imaging.
The primary vascular lesions that would be considered are
cavernous malformations and AVM. The majority of cavernous
malformations occur supratentorial and typically present in the
third through fifth decades of life, rarely in childhood. Cavernous
malformations can have a wide range of radiological appearances
on imaging depending on the lesion type (I–IV) (5). A high grade
lesion will be hyperintense on T1 with a mixed signal on T2,
whereas a low grade lesion will be iso/hypointense on T1 and T2
or poorly visualized (5). These lesions typically have a “popcorn”
appearance and do not enhance with contrast. Arteriovenous
malformations are an abnormal connection between an artery
and vein with an intervening capillary bed. The classical type is
a pial AVM with a glomerular or compact type nidus (6). On
MRI, they have a classic “bag of worms” appearance secondary
to flow voids. They are typically hypointense with a surround-
ing hyperintensity on T2/FLAIR and will enhance with contrast
(7). Given these imaging characteristics the patient presented in
this case did have imaging findings that were consistent with
an AVM.
After reviewing this case, there are a few other ancillary tests
that may have contributed to the diagnosis of this patient. When
confronted with a lesion that has characteristics of multiple dif-
ferent underlying pathologies further studies that can help are
vascular imaging (e.g., MRA, CTA, conventional angiogram) and
functional/metabolic studies (e.g., MR spectroscopy and PET
scans). MR spectroscopy identifies markers of cellular prolifera-
tion and certain profiles are suggestive of neoplastic lesions versus
infection or ischemia (1, 2). Similarly 2-deoxy-2[18F]fluoro--
glucose (FDG)–PET scans analyze the uptake of glucose, which is
increased in malignant tumors. PET scans are especially helpful
for distinguishing recurrent tumor from radiation necrosis (1).
In the patient presented in this case these functional studies
could have helped support a non-neoplastic underlying lesion.
The limitation of these functional studies, especially FDG–PET,
is that low grade neoplasms often have little activity, which can be
misleading. There are several aminotracers available thatmayhave
some benefits over FDG when there is a concern for a low-grade
tumor or non-neoplastic lesion. The primary benefit is that the
uptake of amino acids in normal brain tissues is low, as opposed
to the high uptake of glucose in normal brain tissue, which allows
for the better identification of low grade tumors. L-[methyl-11C]
methionine (MET) and 18F-fluroethyl-tyrosine (FET) are cur-
rently available options, but one limitation is that they are not
commercially available at all institutions (8, 9). Additionally, MET
has a very short half-life (20min) requiring an in-house cyclotron
facility (8, 9). Although these tracers are reported to be more
sensitive and specific than FDG–PET, there are still reports of
increased uptake in the settings of inflammatory cells, reactive
glial tissue, hematomas, ischemia, abscesses, and acute demyelina-
tion, which must be kept in mind. Although these ancillary tests
may not give a definitive diagnosis, they will contribute to the
larger clinical picture. In the case presented, these tests may have
directed the treatment provided more toward a non-neoplastic
lesions, specifically a vascular lesion, whichmay have changed the
surgical approach.
Conclusion
This case of an underlying AVM resulting in a refractory seizure
disorder highlights the challenge in distinguishing neoplastic,
infectious, and vascular lesions based on imaging. MRI can pro-
vide a great deal of information about a lesion and it is important
to carefully analyze available imaging to obtain as much informa-
tion as possible. Additionally, when uncertainty remains about
diagnosis, it may be helpful to utilize other imaging modalities
including vascular imaging, MR spectroscopy, and PET scans.
Finally, when a diagnosis remains unclear, biopsy needs to be
considered, but ultimately it is the entire work-up and clinical
picture that will lead to a correct diagnosis.
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